Latest Convertible Notes News

Page 3 of 83
Identitii’s BNDRY platform gained customers and recurring revenue in FY26, but the company ended the year with just $107,483 in cash, negative net assets and a material uncertainty over its ability to continue as a going concern. A subsequent convertible note facility provides a committed $5 million, while access to a further $15 million remains conditional.
Victor Sage
Victor Sage
30 Sept 2026
Core Energy Minerals has expanded into an advanced Namibian uranium joint venture, but its annual report flags a material uncertainty over continued operations. The explorer reported a $3.369 million loss, $469,346 in cash and a $1.49 million working-capital deficit for 2026.
Victor Sage
Victor Sage
30 Sept 2026
Noble Helium has rebuilt its balance sheet ahead of drilling at Tanzania’s North Rukwa project, but its auditor has warned that future capital raisings remain critical to the company’s survival. The Kinambo campaign is now moving from preparation to execution, with two wells planned and a prospective helium resource still to be proven.
Victor Sage
Victor Sage
30 Sept 2026
Locate Technologies lifted FY26 revenue and grew its Locate2u software business, but a A$4 million debt facility due in November has left auditors flagging material uncertainty over its ability to continue as a going concern. The company ended the year with negative net assets after its loss more than widened.
Sophie Babbage
Sophie Babbage
30 Sept 2026
Jindalee Lithium has advanced its proposed US Elemental Nasdaq listing and prepared to launch major drilling at McDermitt, but its audited FY26 accounts flag a material uncertainty over ongoing funding. The company ended June with A$13.6 million in cash after raising about A$20.4 million, while reporting a A$7.2 million loss and no operating revenue.
Maxwell Dee
Maxwell Dee
29 Sept 2026
Peninsula Energy’s low-pH uranium restart delivered stronger grades but struggled to move enough solution through the Lance wellfields, forcing guidance to be withdrawn and triggering a US$50.1 million impairment. Auditors flagged material uncertainty over the company’s ability to continue as a going concern, despite fresh funding and a reconfirmed CY2027 production target.
Maxwell Dee
Maxwell Dee
29 Sept 2026
Duxton Farms has warned of a material uncertainty around its ability to continue as a going concern after a merger-driven loss, sharply higher borrowings and heavy cash outflows. The agricultural group is relying on asset sales, cost reductions and fresh funding while it tries to shift from mature broadacre assets into longer-dated development projects.
Ada Torres
Ada Torres
29 Sept 2026
AdNeo Limited (ASX: AD1) nearly doubled operating revenue in FY26 and delivered its first full-year operating cash inflow, marking a sharp turnaround after the Learnt Global acquisition. The recovery remains incomplete, with a $3.97 million loss, significant current liabilities and an auditor-drawn material uncertainty over going concern.
Sophie Babbage
Sophie Babbage
29 Sept 2026
Memphasys will receive an A$3.5 million advance from major shareholder Peters Investments to expand Felix production, inventory and sales capacity as repeat orders emerge across international markets. The funding carries a 12.5% interest rate, potential equity dilution and requires shareholder and ASX approvals before the convertible notes can be issued.
Ada Torres
Ada Torres
29 Sept 2026
Revolver Resources has taken its Dianne Copper Mine Project from study towards construction readiness, with a larger resource, secured approvals and a forecast $125.7 million pre-tax cash flow. But the restart still depends on project-level funding before a Final Investment Decision can be made.
Maxwell Dee
Maxwell Dee
29 Sept 2026
Mantle Minerals reported a $12.50 million FY2026 profit after selling Mt Roe Mining to Northern Star for $13.5 million, while continuing operations remained loss-making. The company ended the year with $5.50 million in cash and is redirecting capital towards Yule River and Carlton Hill exploration.
Maxwell Dee
Maxwell Dee
28 Sept 2026
Patrys has moved its injectable quetiapine program into human testing, while its FY2026 annual report warns the company will need further funding within 12 months. The company ended the year with $3.36 million in cash after raising capital and acquiring the RLS-2202 development program.
Victor Sage
Victor Sage
28 Sept 2026

Browse the archive

Full archive